Publications by authors named "Moshe Pahmer"

Claim this Profile
A
A Further Case for Targeting PRMT5 and the ERK1/2 and PI3K Pathways in CRC.
Mark Spivak, Moshe Pahmer, Dorna Delrahimnia, Tzuriel Sapir, David Shifteh

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5-KRAS Crosstalk.
Mark Spivak, Moshe Pahmer, Dorna Delrahimnia, Tzuriel Sapir, David Shifteh

Curr Issues Mol Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer.
Tzuriel Sapir, David Shifteh, Moshe Pahmer, Sanjay Goel, Radhashree Maitra

Mol Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Arginine Methyltransferase 5 as a Therapeutic Target for Mutated Colorectal Cancer.
David Shifteh, Tzuriel Sapir, Moshe Pahmer, Adam Haimowitz, Sanjay Goel

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis